Genitourinary Drugs Market Report by Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence and Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), Product (Urological, Hormonal Therapy, Gynecological, Anti-infectives, and Others), and Region 2024-2032

Genitourinary Drugs Market Report by Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence and Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), Product (Urological, Hormonal Therapy, Gynecological, Anti-infectives, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A4727
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Genitourinary Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Indication
    6.1    Prostate Cancer
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Ovarian Cancer
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Bladder Cancer
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cervical Cancer
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Renal Cancer
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Erectile Dysfunction
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Urinary Tract Infections
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Urinary Incontinence and Overactive Bladder
        6.8.1 Market Trends
        6.8.2 Market Forecast
    6.9    Sexually Transmitted Diseases
        6.9.1 Market Trends
        6.9.2 Market Forecast
    6.10    Interstitial Cystitis
        6.10.1 Market Trends
        6.10.2 Market Forecast
    6.11    Hematuria
        6.11.1 Market Trends
        6.11.2 Market Forecast
    6.12    Benign Prostatic Hyperplasia
        6.12.1 Market Trends
        6.12.2 Market Forecast
7   Market Breakup by Product
    7.1    Urological
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Hormonal Therapy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Gynecological
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Anti-infectives
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9   SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10  Value Chain Analysis
11  Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12  Price Analysis
13  Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Allergan plc (AbbVie Inc.)
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 SWOT Analysis
        13.3.2    Antares Pharma Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
        13.3.3    AstraZeneca plc
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
        13.3.4    Bayer AG
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    Bristol-Myers Squibb Company
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Genentech Inc. (Roche Holding AG)
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 SWOT Analysis
        13.3.7    GlaxoSmithKline plc
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
           13.3.7.4 SWOT Analysis
        13.3.8    Merck & Co. Inc.
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Novartis AG
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Pfizer Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Teva Pharmaceutical Industries Ltd.
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials

List of Figures

Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2023
Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2023
Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2023
Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2023
Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 5: Global: Genitourinary Drugs Market: Competitive Structure
Table 6: Global: Genitourinary Drugs Market: Key Players

Genitourinary Drugs Market Report by Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence and Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), Product (Urological, Hormonal Therapy, Gynecological, Anti-infectives, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More